CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Very importantly, the frequency of untreated CML CD34+ cells (1/185) measured by LTC-IC/LDA was only slightly reduced by IMA (1/240), while BJE6 alone was very effective at significantly reducing their frequency, by 3.1-fold (1/565) (Figure 5C,D).